A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors

Inclusion Criteria: * PATIENT: Carry a diagnosis of BCR-ABL-negative MPN or CML * PATIENT: Have an estimated life expectancy of at least 6 months, assessed by principal investigator or treating investigator * PATIENT: Be able to speak and read English * PATIENT: Be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet (assessed by participant self-report) * PATIENT: Have daily access to a mobile phone capable of receiving text messages, as determined by a study investigator * PATIENT: Be able to provide informed consent * CAREGIVER: Be a spouse/partner, other family member, or a close friend of a BCR-ABL-negative patient who consented to participate in the Being Present-MPN study * CAREGIVER: Be able to speak and read English * CAREGIVER: Be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet (assessed by participant self-report) * CAREGIVER: Have access to a mobile phone capable of receiving text messages, as determined by a study investigator * CAREGIVER: Be able to provide informed consent Exclusion Criteria: * PATIENT: Have had their BCR-ABL-negative MPN transform into acute leukemia * PATIENT: Have had their CP-CML transform into blast phase * PATIENT: Be post-allogeneic stem cell transplantation * PATIENT AND CAREGIVER: Have extensive hearing loss such that ability to participate in the study would be impaired